Skip to main content
. 2022 Sep 9;14(9):1914. doi: 10.3390/pharmaceutics14091914

Figure 8.

Figure 8

Drug–Protein Interaction network in AD. FDA-approved drugs (phase 4) with reported activity against AD-targets, data were retrieved on July 2022 from ChEMBL database (v31) using the “phembl_value” as search criteria. For further details, see the Supplementary Materials.